| Atrial fibrillation after implantable cardioverter defibrillator implantation. | |
| | |
MedLine Citation:
|
PMID: 7770356 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Atrial fibrillation is a reported complication of automatic defibrillator implantation. Its incidence, risk factors, time-course, and complications have not been well-defined. Accordingly, data from 117 patients who underwent defibrillator implantation via a thoracotomy (n = 71) or nonthoracotomy (n = 46) approach were reviewed. To identify risk factors, 15 variables of potential predictive value were chosen and analyzed. Atrial fibrillation developed in 26/117 patients (22%) during the early postoperative period and all but one of these 26 patients had undergone thoracotomy (P < 0.001). Patients who developed atrial fibrillation tended to be older than those who did not (63 +/- 2 vs 58 +/- 2 years, P = 0.04) and more frequently had a prior history of paroxysmal atrial fibrillation (31% vs 10%, P = 0.02). They were also less likely to be taking Class I or III antiarrhythmic drugs (1/26 vs 24/91, P = 0.01). By multivariate analysis, operative approach (P < 0.001), the absence of antiarrhythmic drug therapy (P = 0.006), and a prior history of atrial fibrillation (P = 0.003) were significant independent variables. Digoxin neither prevented the occurrence of atrial fibrillation nor slowed the maximal ventricular response. The mortality and complication rates did not differ between the two groups. The major adverse effect of postimplant atrial fibrillation was automatic defibrillator discharge; six patients received between 1 and 11 discharges for atrial fibrillation with rapid ventricular rates. |
| | |
Authors:
|
P A Kelly; D E Mann; M J Reiter; A H Harken |
Related Documents
:
|
16784926 - Determinants of thoracic electrical impedance in external electrical cardioversion of a... 14508146 - Arrhythmias in the intensive care patient. 7681026 - Pathophysiology of atrial fibrillation: current aspects. 8950056 - Role of echocardiography in the evaluation and management of atrial fibrillation. 19726816 - Effects of the number and interval of balloon inflations during primary pci on the exte... 8551786 - Attenuation of cardiopulmonary bypass-derived inflammatory reactions reduces myocardial... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Pacing and clinical electrophysiology : PACE Volume: 18 ISSN: 0147-8389 ISO Abbreviation: Pacing Clin Electrophysiol Publication Date: 1995 Mar |
Date Detail:
|
Created Date: 1995-07-05 Completed Date: 1995-07-05 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 7803944 Medline TA: Pacing Clin Electrophysiol Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 379-85 Citation Subset: IM |
Affiliation:
|
University of Colorado Health Sciences Center, Denver 80262, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adolescent Adult Aged Aged, 80 and over Anti-Arrhythmia Agents / therapeutic use Atrial Fibrillation / diagnosis, etiology* Defibrillators, Implantable / adverse effects* Female Humans Male Middle Aged Risk Factors Thoracotomy |
| Chemical | |
Reg. No./Substance:
|
0/Anti-Arrhythmia Agents |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Better health care for people with learning disabilities.
Next Document: Evaluation of a new rate adaptive ventricular pacemaker controlled by double sensors.